249 related articles for article (PubMed ID: 28787086)
1. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Nguyen KA; Syed JS; Espenschied CR; LaDuca H; Bhagat AM; Suarez-Sarmiento A; O'Rourke TK; Brierley KL; Hofstatter EW; Shuch B
Cancer; 2017 Nov; 123(22):4363-4371. PubMed ID: 28787086
[TBL] [Abstract][Full Text] [Related]
2. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
[TBL] [Abstract][Full Text] [Related]
3. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
4. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
5. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
[TBL] [Abstract][Full Text] [Related]
6. [Spontaneous pneumothorax as the first manifestation of a hereditary condition with an increased renal cancer risk].
Johannesma PC; Lammers JW; van Moorselaar RJ; Starink TM; Postmus PE; Menko FH
Ned Tijdschr Geneeskd; 2009; 153():A581. PubMed ID: 19857281
[TBL] [Abstract][Full Text] [Related]
7. Genetic kidney cancer syndromes.
Ho TH; Jonasch E
J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of cancer of the kidney.
Linehan WM; Walther MM; Zbar B
J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
[TBL] [Abstract][Full Text] [Related]
9. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
10. The changing approach for identifying hereditary colorectal cancer syndromes.
Laghi L; Ricciardiello L
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):593-594. PubMed ID: 32651554
[No Abstract] [Full Text] [Related]
11. Familial and hereditary renal cancer syndromes.
Coleman JA
Urol Clin North Am; 2008 Nov; 35(4):563-72; v. PubMed ID: 18992610
[TBL] [Abstract][Full Text] [Related]
12. Birt-Hogg-Dubé (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene.
Palmirotta R; Donati P; Savonarola A; Cota C; Ferroni P; Guadagni F
Eur J Dermatol; 2008; 18(4):382-6. PubMed ID: 18573707
[TBL] [Abstract][Full Text] [Related]
13. Advances in the recognition and management of hereditary cancer.
Kulkarni A; Carley H
Br Med Bull; 2016 Dec; 120(1):123-138. PubMed ID: 27941041
[TBL] [Abstract][Full Text] [Related]
14. Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic.
McFadden J; Hardesty J; Schroeder C; Vance GH; Boris RS
Urol Oncol; 2024 Mar; 42(3):72.e19-72.e25. PubMed ID: 38267302
[TBL] [Abstract][Full Text] [Related]
15. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
16. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
Dommering CJ; Henneman L; van der Hout AH; Jonker MA; Tops CM; van den Ouweland AM; van der Luijt RB; Mensenkamp AR; Hogervorst FB; Redeker EJ; de Die-Smulders CE; Moll AC; Meijers-Heijboer H
Fam Cancer; 2017 Apr; 16(2):271-277. PubMed ID: 27826806
[TBL] [Abstract][Full Text] [Related]
17. Inherited kidney cancer syndromes.
Ball MW; Shuch BM
Curr Opin Urol; 2019 Jul; 29(4):334-343. PubMed ID: 31083011
[TBL] [Abstract][Full Text] [Related]
18. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
[TBL] [Abstract][Full Text] [Related]
19. Strategies for clinical implementation of screening for hereditary cancer syndromes.
Heald B; Marquard J; Funchain P
Semin Oncol; 2016 Oct; 43(5):609-614. PubMed ID: 27899194
[TBL] [Abstract][Full Text] [Related]
20. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
